|Video: CEO of Pressure BioSciences sees firm’s momentum continuing to build in 2012|
|By Staff and Wire Reports|
|Monday, 27 February 2012 08:30|
Pressure BioSciences Inc. is a life sciences company focused on the development of a novel, enabling technology called pressure cycling technology (PCT). The company is engaged in the research development and commercialization of products utilizing its patented pressure cycling technology for the control of bio-molecular interactions.
PBI's Pressure Cycling Technology (PCT) uses rapid cycles of hydrostatic pressure between ambient and ultra high levels to control biomolecular interactions, allowing for a high degree of precision, reproducibility, convenience, speed, and safety. This unique, patented technology offers the potential for broad applications in a number of established and emerging fields, including genomics, proteomics, drug discovery & development, process purification, pathogen inactivation, immunodiagnostics, and DNA sequencing.
About the CEO:
Mr. Richard T. Schumacher, is the founder of the company, has served as a director of the Company since 1978. He has served as Chief Executive Officer of the Company since April 16, 2004 and President since September 14, 2004. He previously served as Chief Executive Officer and Chairman of the Board of the Company from 1992 to February 2003. From July 9, 2003 until April 14, 2004, he served as a consultant to the Company pursuant to a consulting agreement. He served as President of the Company from 1986 to August 1999. Mr. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Mr. Schumacher received a B.S. in Zoology from the University of New Hampshire.